Clinical trial Recruiting at 2 sites Interventional Ages 18 to 40

Comparing MTA versus Biodentine for complete pulpotomy in painful molars

Official title: Short Term Outcome of Complete Pulpotomy Using MTA vs Biodentine in Symptomatic Irreversible Pulpitis - A Randomized Controlled Trial

Run by Dow University of Health Sciences · NCT07483788 · Data updated 2026-11-12

This will test whether MTA or Biodentine works better to relieve pain and preserve the tooth in adults (18–40) with symptomatic irreversible pulpitis in a molar.

More Symptomatic Irreversible Pulpitis (SIP) trials

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorDow University of Health Sciences
Academic / other
Locations2 sites (Karachi, Sindh and 1 other locations)
StatusRecruiting
StartedNovember 2, 2024
Main results expectedNovember 30, 2026
Study endsDecember 30, 2026
Registry record updatedOctober 20, 2026
Trial IDNCT07483788 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–40 with cariously exposed molars, moderate-to-severe pain (VAS 4–10), positive cold/EPT indicating symptomatic irreversible pulpitis, a periapical index of 1, and where hemostasis can be achieved within 10 minutes are ideal candidates.

Probably not a fit

Patients with traumatic injuries, non-restorable lesions, immature/open root apices, internal or external resorption, calcified canals, or those who cannot achieve hemostasis within 10 minutes are unlikely to benefit from this procedure.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–40 who present with moderate to severe pain from cariously exposed maxillary or mandibular molars and meet diagnostic tests for symptomatic irreversible pulpitis will be treated at Dow University of Health Sciences. Treatment is done by one dentist over two visits with local anesthesia and rubber-dam isolation; the coronal pulp is removed, bleeding controlled within 10 minutes, and then either MTA or Biodentine is placed. Pain will be recorded on a 1–10 scale and baseline tests include cold test, electric pulp testing, and a periapical radiograph; follow-up focuses on short-term clinical outcomes. The trial compares the two biomaterials' performance for complete pulpotomy in this specific patient group at a single center in Karachi.

Why it matters

Potential benefit: If successful, the finding could offer a reliable, less invasive option to quickly relieve pain while preserving the tooth's vitality.

How similar studies have gone: Previous clinical reports have shown promising short-term success using MTA for pulpotomy and emerging evidence suggests Biodentine often achieves similar outcomes, though follow-up durations vary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Teeth of generally healthy patients having following criteria will be included:

1. Age between 18-40 years of both males and females
2. Carious exposed maxillary and mandibular molars teeth
3. Moderate to severe pain (VAS 4-10)
4. Diagnosed with Symptomatic irreversible pulpitis on cold test and Electric pulp test (EPT)
5. Periapical index of 1
6. Hemostasis is achieved within 10 mins after full pulpotomy

Exclusion Criteria:

Teeth of generally healthy patients having following criteria will be excluded:

1. Any traumatic injury
2. Non-restorable carious lesion
3. Immature or Open apices of roots
4. Internal or external Resorption
5. Calcified canals

Where it's running

  • Dr Khadija Zubair
    Karachi, Sindh, Pakistan
    Recruiting
  • Dr Khadija Zubair
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

  • Principal investigator: Dr Khadija Zubair, Postgraduate Trainee- FCPS — Dow University of Health Sciences
  • Study coordinator: Dr Khadija Zubair, Postgraduate trainee- FCPS
  • Email: khadija.zubair21@yahoo.com
  • Phone: 03363605145

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.